SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-009277
Filing Date
2020-08-05
Accepted
2020-08-05 07:13:40
Documents
88
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcyc-20200630x10q.htm 10-Q 2130662
2 EX-10.2 bcyc-20200630ex102d97c15.htm EX-10.2 474011
3 EX-31.1 bcyc-20200630ex311446e2a.htm EX-31.1 13732
4 EX-31.2 bcyc-20200630ex3124dfa79.htm EX-31.2 13712
5 EX-32.1 bcyc-20200630ex32154d16d.htm EX-32.1 10958
6 GRAPHIC bcyc-20200630ex102d97c15001.jpg GRAPHIC 4073
  Complete submission text file 0001558370-20-009277.txt   9059194

Data Files

Seq Description Document Type Size
7 EX-101.INS bcyc-20200630.xml EX-101.INS 1769302
8 EX-101.SCH bcyc-20200630.xsd EX-101.SCH 80301
9 EX-101.CAL bcyc-20200630_cal.xml EX-101.CAL 45456
10 EX-101.DEF bcyc-20200630_def.xml EX-101.DEF 309394
11 EX-101.LAB bcyc-20200630_lab.xml EX-101.LAB 588626
12 EX-101.PRE bcyc-20200630_pre.xml EX-101.PRE 486563
Mailing Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 011441223261503
BICYCLE THERAPEUTICS plc (Filer) CIK: 0001761612 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-38916 | Film No.: 201075612
SIC: 2834 Pharmaceutical Preparations